AI
Wednesday, April 13, 2011 7:54:42 PM
SNY won't admit it but they had a shortage for all syringe doses especially the HD syringes because they were anticipating a TEVA entry that never came into fruition..
So all along TEVA has been secretly helping MNTA out by the BS "we will be approved next month" claims.
Is there any "stickyness" in this effect? Once the shortage is over will there be less of a gap between the product price/demand curves than there would have been w/o the shortage?
Might Sandoz need to raise prices a bit?
So all along TEVA has been secretly helping MNTA out by the BS "we will be approved next month" claims.
Is there any "stickyness" in this effect? Once the shortage is over will there be less of a gap between the product price/demand curves than there would have been w/o the shortage?
Might Sandoz need to raise prices a bit?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
